Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients

BACKGROUND: The benefit of aerosolized ribavirin (AR) in reducing the risk of progression of RSV infections and RSV-associated mortality in HCT recipients has been recognized, yet there is a paucity of data assessing the use of oral ribavirin (OR) in this patient population. We evaluated outcomes as...

Descripción completa

Detalles Bibliográficos
Autores principales: Foolad, Farnaz, Aitken, Samuel L, Prayag, Amrita, Ghantoji, Shashank S, Ariza-Heredia, Ella, Shah, Dimpy P, Chemaly, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107211/
http://dx.doi.org/10.1093/ofid/ofx163.1358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7107211/
http://dx.doi.org/10.1093/ofid/ofx163.1358

Ejemplares similares